Stockscreener 앱 받기
2.34
15.27%
0.31
전일 마감가:
$2.03
열려 있는:
$2.07
하루 거래량:
1.05M
Relative Volume:
1.59
시가총액:
$339.24M
수익:
$28.94M
순이익/손실:
$-54.29M
주가수익비율:
-5.0355
EPS:
-0.4647
순현금흐름:
$-26.02M
1주 성능:
+0.00%
1개월 성능:
+2.18%
6개월 성능:
+16.42%
1년 성능:
+41.82%
1일 변동 폭
$2.05
$2.34
1주일 범위
$2.00
$2.38
52주 변동 폭
$1.30
$2.79
Omniab Inc Stock (OABI) Company Profile
명칭
Omniab Inc
전화
510-250-7800
주소
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.34 | 339.24M | 28.94M | -54.29M | -26.02M | -0.4647 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-21 | 개시 | The Benchmark Company | Buy |
| 2023-04-13 | 개시 | Craig Hallum | Buy |
| 2023-02-22 | 개시 | Cowen | Outperform |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-11-29 | 개시 | SVB Leerink | Outperform |
| 2022-11-28 | 개시 | Stifel | Buy |
모두보기
Omniab Inc 주식(OABI)의 최신 뉴스
OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com - Investing.com Australia
OmniAb shareholders elect directors and ratify auditor at annual meeting - Investing.com UK
OmniAb Shareholders Approve Directors and Auditor at Meeting - TipRanks
OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants - Stock Titan
OmniAb (OABI) director adds shares through RSU vesting and new equity grants - Stock Titan
OmniAb (OABI) director receives options and RSUs, exercises 20,000 shares - Stock Titan
OmniAb (OABI) director granted stock options and RSUs - Stock Titan
OmniAb (OABI) director adds options and RSUs in Form 4 filing - Stock Titan
OmniAb (OABI) director gains stock, options and RSUs in Form 4 - Stock Titan
OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor - Stock Titan
OmniAb Inc (OABIW) Institutional Confidence - TradingKey
OmniAb Inc (OABIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Is OmniAb Gaining Attention In The Biotechnology Landscape? - Kalkine Media
OmniAb Inc (OABI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Institutional Confidence - TradingKey
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc (OABIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
OmniAb Inc (OABI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OABI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentAnalyst Consensus Shift - newsline.com
OmniAb, Inc. Hits New 52-Week High of $2.79 Amidst Market Challenges - MarketsMojo
Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth - Yahoo Finance
OABI Stock Price, Quote & Chart | OMNIAB INC (NASDAQ:OABI) - ChartMill
OmniAb Inc. (OABI) Edges Lower as Stock Nears Key Support ZoneFibonacci Retracement - newsline.com
OmniAb (OABI) Hovers Near Key Support After Slight DeclineRunaway Gap - The Legal Advocate
OABI Q1 2026 Earnings: EPS Beat Masks Ongoing R&D InvestmentsUpward Estimate Revision - newsline.com
OABI Q1 2026 Earnings: Wider-than-Expected Loss Narrows as EPS Surprises PositivelyEarnings Yield Spread - newsline.com
OmniAb, Inc. Hits New 52-Week High at USD 2.73 - Markets Mojo
OmniAb Stock Is Back Near Its High — Why OABI’s Next Few Days Matter - Bez Kabli
OmniAb Inc. (OABI) Gains 3.92% as Stock Approaches Key Resistance at $2.78Narrow Range Breakout - newsline.com
OmniAb Inc. (OABI) Shares Edge Higher as Key Support HoldsOn Balance Volume - thelegaladvocate.com
OmniAb Inc. (OABI) Rallies 3.9% as Stock Tests Key Resistance LevelsLinear Regression - The Legal Advocate
Is OmniAb Positioned To Be A Long-Term Biotech Winner? - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
OmniAb, Inc. Common Stock OABI ) Stock Price Today & Analysis - Gotrade
OmniAb unveils OmniUltra in vivo platform at TIDES USA event - Traders Union
OmniAb, Inc. (OABI) reports Q1 loss, tops revenue estimates - MSN
We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely - Moomoo
TradingKey - TradingKey
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook - MSN
OmniAb, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OABI) 2026-05-11 - Seeking Alpha
Number of shareholders of OmniAb, Inc. – NASDAQ:OABIW - TradingView
Omniab Inc (OABI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.44%
자본화:
|
볼륨(24시간):